Celldex Therapeutics, Inc. (NASDAQ:CLDX)
CAPS Rating:
A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.
RSS Headlines
Fool UK
Recs
Extremely undervalued pipeline with gamechanging technology...biotech value at its best!
Today´s conference call http://tinyurl.com/2c5dw46
Not mine, but good look at current clinical trials show just how undervalued this is... http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_C/threadview?m=te&bn=78350&tid=25162&mid=25162&tof=10&frt=1#25162